Will they cry over this spilt milk?

February 1994
U.S. News & World Report;2/14/94, Vol. 116 Issue 6, p6
Reports that Monsanto Co. has poured some $300 million dollars into developing bST, a bioengineered version of a natural cow hormone. Marketing under the brand name Posilac, bST encourages cows to give more milk. Consumer activists who protested the sale of bST; Companies monitoring bST; Monsanto's worries about consumer fears and activist groups' protests.


Related Articles

  • News wire.  // Dairy Field;Aug96, Vol. 179 Issue 8, p1 

    Reports that Atlanta, Georgia is the site for Monsanto's first United States production for recombinant bovine growth hormone, according to the `Wisconsin State Journal.'

  • Monsanto says `trust me,' makes Bossie a cash cow. McCarthy, Colman // National Catholic Reporter;3/18/94, Vol. 30 Issue 20, p16 

    Opinion. Comments on Monsanto Co.'s bovine somatotropin (BST) growth hormone that artificially stimulates cows to give more milk. Suit against Iowa dairy cooperative; Plans for national boycott; Core issues of trust and choice; Claims by Food and Drugs Administration; Criticism of Pure Food...

  • Corporate security: Monsanto's `first amendment' right to lie. Grossman, Richard // Earth Island Journal;Winter96/97, Vol. 12 Issue 1, p25 

    Examines the controversy surrounding the use of Monsanto Co.'s genetically engineered bovine growth hormone called rBST. Opposition to the law passed by the state of Vermont that require the labeling of products containing rBST; Arguments on the issue of labeling and information. INSET:...

  • Monsato wins approval for bovine hormone. Kirschner, Elisabeth // Chemical Week;11/17/1993, Vol. 153 Issue 19, p9 

    Reports on Food and Drug Administration's approval granted to Monsanto Co. to market bovine somatotropin (BST), a hormone that increases milk production in cows. Non-requirement of labelling milk and meat from BST-treated cows; Monsato's marketing strategy to start in February 1994; European...

  • Monsanto `improperly promoted' BST.  // Chemical Week;10/26/1994, Vol. 155 Issue 15, p5 

    Reports that Monsanto improperly promoted its bovine somatotropin (BST) before it had won Food and Drug Administration approval.

  • Launching Posilac to dairy farmers. Fried-Cassorla, Albert // Agri Marketing;Mar1994, Vol. 32 Issue 3, p44 

    Discusses the strategy used by Monsanto Animal Sciences Division in launching the bovine somatotropin (BST) POSILAC. Assembly of a marketing database; Key participants; Tracking of information from its sales force activity; Provision of technical information through meetings.

  • Plagiarism or protecting public health? Millstone, Erik; Brunner, Eric // Nature;10/20/1994, Vol. 371 Issue 6499, p647 

    Comments on Monsanto Co.'s decision to block publication of the authors' paper attempting to determine whether the milk produced using bovine somatotropin (BST) is hazardous to animal health. Authors' denial of the company's allegation that they committed plagiarism; Company's efforts to...

  • Boo to moo?  // Mothering;Mar/Apr99, Issue 93, p31 

    Reports on studies that have raised doubts about the safety of recombinant bovine growth hormone (RcBG), a manmade genetically engineered hormone given to cows to increase their milk production. Canadian study that reviewed data used by RcBG manufacturer Monsanto to obtain United States...

  • ...and sues dairies.  // Chemical Week;3/2/1994, Vol. 154 Issue 8, p6 

    Reports on Monsanto Co.'s lawsuits against two dairy producers for advertising that their products were not made from cows treated with Monsanto's bovine somatotropin (BST). Charge of unfair competition; Food and Drug Administration's guidelines; Comment on BST sales.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics